Thursday, December 16, 2004

From the Globe and Mail:
Ottawa approves drug for advanced Alzheimer's disease
Health Canada has approved for sale the first drug aimed at improving life for people with moderate to severe Alzheimer's disease, and, by extension, for the people who look after them.

The drug, sold under the brand name Ebixa, does not cure or reverse the damage done by the devastating disease, which is estimated to affect about 238,000 Canadians.

No comments: